Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...

The US Food and Drug Administration (FDA) has awarded Neuralink’s brain-computer interface breakthrough device designation ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

The company said that its applications can be extended to individuals affected by ALS, stroke, spinal cord injury, cerebral ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

The US Food and Drug Administration (FDA) has granted 'breakthrough device' status to Neuralink’s experimental speech ...

The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S ...

Neuralink, Elon Musk's brain implant company, has secured the US FDA's breakthrough tag for its speech restoration device ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...